|
Orthologous residues
|
|
CREB (human): S121‑p, CREB (mouse): S121‑p, CREB (rat): S121‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phospho-antibody, western blotting
|
|
Disease tissue studied:
leukemia, chronic myelogenous leukemia
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), K562 (erythroid)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATM (human)
|
genetic knockout/knockin of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
H2O2
|
|
|
|
increase
|
|
|
ionizing radiation
|
|
|
|
increase
|
|
|
UV
|
|
|
|
increase
|
|
|
aphidicolin
|
|
|
|
increase
|
|
|
deferoxamine
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
inhibition
|
|
Effect of modification (process):
transcription, altered
|